Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy

Our results revealed that IL-6−induced aberrant activation of STAT3-mediated overproduction of galactose-deficient IgA1. STAT3 signaling pathway may thus represent a new target for disease-specific therapy of IgA nephropathy.